Amgen Receives FDA Approval for Lumakras
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214665
Humanigen Files US Emergency Use Application For Lenzilumab For COVID-19
Humanigen Inc (NASDAQ:HGEN) has submitted an application to the FDA seeking Emergency Use Authorization (EUA) for lenzilumab to treat patients hospitalized…
FDA Advisory Committee Votes In Favor Of Approval Of Provention Bio’s Diabetes Med
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted 10-7 in favor of recommending ap
AstraZeneca Announced Tagrisso Approved in EU in Early Lung Cancer
AstraZeneca's (NYSE: AZN) Tagrisso (osimertinib) has been approved in the European Union (EU) for the adjuvant treatment of adult patients with early-stage (IB, II and IIIA) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after complete tumour resection with curative intent.
Cyclerion Therapeutics Highlights Publication Of CY6463 Preclinical Data In Frontiers In Pharmacology
Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) today announced the publication of preclinical data of CY6463 in Frontiers in Pharmacology. Cyclerion is developing CY6463, an oral, first-in-class, central nervous
Justice Department Opens Probe In Presumed lapses at Eli Lilly’s COVID-19 Drug Plant: Reuters
The U.S. Justice Department has launched a criminal investigation into Eli Lilly and Co (NYSE:LLY) focused on alleged manufacturing irregularities…
Myriad Genetics Submits sPMA for myChoice CDx with Zejula in First-Line Platinum Responsive Advanced Ovarian Cancer
Myriad Genetics, Inc. (NASDAQ:MYGN) announced that it has submitted a supplementary premarket approval (sPMA) application to the U.S.…
Biohaven’s Verdiperstat Receives FDA ‘May Proceed’ Letter To Initiate Trial In Amyotrophic Lateral Sclerosis Conducted By The Healey Center For ALS At Mass General
Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) (“Biohaven” or the “Company”), a biopharmaceutical company with multiple late-stage neuroscience drug…
Despite Bright Prospects, Credit Suisse Begins Thermo Fisher With Neutral Rating
Although Thermo Fisher Scientific Inc. (NYSE:TMO) seems well-positioned to generate robust organic revenue growth and healthy margin expansion…
Neurotrope Rips 150% Higher On Improved Alzheimer’s Data, NIH Funding
Shares of thinly-traded microcap biopharma Neurotrope Inc (NASDAQ:NTRP) gap-opened sharply higher on above 50 times average volume following…